Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-20

Clinical Trial Update: A Phase Ⅱ Study of Mosapride Citrate Injection in the Treatment of Postoperative Gastrointestinal Dysfunction [Phase 2]

View source ↗

Summary

This entry notes a Phase 2 clinical trial evaluating Mosapride Citrate Injection for postoperative gastrointestinal dysfunction, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mosapride Citrate Injection (mosapride citrate)

Snippet

Sponsor: Shandong New Time Pharmaceutical Co., LTD | Conditions: Postoperative Gastrointestinal Dysfunction | Phase 2 | Status: RECRUITING